Early Alert for Baxter Duo-Vent Solution Sets
Baxter has recommended removal of certain Duo-Vent solution sets used for administration of fluids to the patient's vascular system.
Baxter has recommended removal of certain Duo-Vent solution sets used for administration of fluids to the patient's vascular system.
A recent cruise ship outbreak of the Andes strain underscores the potential for silent spread and severe respiratory complications in travel networks.
The FDA will review a New Drug Application for Apnimed's AD109, an investigational oral pill for the treatment of adults with obstructive sleep apnea with a target action date of Feb 28, 2027.
American Lung Association is launching a new initiative to help the more than 16 million people in the US living with COPD manage symptoms and improve quality of life.